Adamis Pharmaceuticals (ADMP) announced that it has finalized the private placement of 1,724,137 shares of Series A-2 Convertible Preferred Stock and warrants to purchase up to 1,724,137 shares of common stock and/or Series A-2 Preferred Stock generating gross proceeds of ~$5M. The Preferred and warrants were sold as units at $2.90, each unit consisting of one share of Preferred and one warrant. Each share of Preferred is convertible into one share of common at any time at the investor's discretion. Each five-year warrant is exercisable at $2.90 a share.